Alresayes Saad, Al Deeb Modhi, Mokeem Sameer A, Al-Hamoudi Nawwaf, Ahmad Paras, Al-Aali Khulud A, Vohra Fahim, Abduljabbar Tariq
Department of Prosthetic Dental Science, College of Dentistry, King Saud University, Riyadh, 11545, Saudi Arabia.
Department of Periodontics and Community Dentistry, King Saud University, Riyadh, 11545, Saudi Arabia.
Photodiagnosis Photodyn Ther. 2020 Sep;31:101831. doi: 10.1016/j.pdpdt.2020.101831. Epub 2020 May 22.
Obesity appears to govern peri-implant hard and soft tissue health. We hypothesized that adjunctive photodynamic therapy (aPDT), improves clinical peri-implant perimeters and alleviates peri-implant crevicular fluid (PICF) levels of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and high sensitivity C-reactive protein (hsCRP) in obese with moderate peri-implantitis. The current clinic-laboratory study aimed to determine whether obesity influences the outcomes of aPDT in patients with moderate peri-implantitis.
A total of 49 patients (24 obese and 25 non-obese) with moderate periodontitis receiving aPDT were included. Clinical characteristics including peri-implant probing depth (PIPD), peri-implant bleeding on probing (PIBOP), and peri-implant plaque index (PIPI) were measured. PICF levels of TNF-a, IL-6 and hsCRP were assessed using enzyme-linked immunosorbent assay (ELISA). Both clinical and cytokine assessments were performed at baseline, three months and six months, respectively. Intra-group comparisons of changes in clinical parameters pre and post PDT was performed using Friedman test. Comparison of changes of TNF-a, IL-6 and hsCRP levels within group was performed using Kruskal-Wallis test.
When compared with the baseline, a considerable reduction in PIPI, PIBOP and PIPD was observed in obese as well as non-obese patients at three- and six-months follow-up. At three months follow-up, a statistically significant difference was observed in PIPI (p < 0.05), PIBOP (p < 0.05) and PIPD (p < 0.05) among obese and non-obese individuals. Additionally, when compared with the baseline, a statistically significant difference was noticed in PICF volume (p < 0.05) and levels of TNF-α (p < 0.05) and IL-6 (p < 0.05) in non-obese as well as obese at three- and six-months follow-up.
With the application of aPDT, considerable improvement was observed in peri-implant inflammatory parameters among obese and non-obese patients with moderate peri-implantitis. Obesity did not appear to influence aPDT outcome in patients with moderate peri-implantitis.
肥胖似乎影响种植体周围软硬组织健康。我们假设辅助光动力疗法(aPDT)可改善肥胖伴中度种植体周炎患者的种植体周围临床指标,并降低种植体周围龈沟液(PICF)中肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6和高敏C反应蛋白(hsCRP)的水平。当前这项临床实验室研究旨在确定肥胖是否会影响中度种植体周炎患者接受aPDT的治疗效果。
本研究共纳入49例接受aPDT治疗的中度种植体周炎患者(24例肥胖患者和25例非肥胖患者)。测量种植体周围探诊深度(PIPD)、种植体周围探诊出血(PIBOP)和种植体周围菌斑指数(PIPI)等临床指标。采用酶联免疫吸附测定(ELISA)法评估PICF中TNF-α、IL-6和hsCRP的水平。临床指标和细胞因子评估分别在基线、3个月和6个月时进行。采用Friedman检验对PDT前后临床参数的变化进行组内比较。采用Kruskal-Wallis检验对组内TNF-α、IL-6和hsCRP水平的变化进行比较。
与基线相比,肥胖和非肥胖患者在3个月和6个月随访时,PIPI、PIBOP和PIPD均有显著降低。在3个月随访时,肥胖和非肥胖个体之间的PIPI(p < 0.05)、PIBOP(p < 0.05)和PIPD(p < 0.05)存在统计学显著差异。此外,与基线相比,非肥胖和肥胖患者在3个月和6个月随访时,PICF量(p < 0.05)以及TNF-α水平(p < 0.05)和IL-6水平(p < 0.05)均存在统计学显著差异。
应用aPDT后,肥胖和非肥胖的中度种植体周炎患者的种植体周围炎症参数均有显著改善。肥胖似乎并未影响中度种植体周炎患者接受aPDT的治疗效果。